NM Al-Khero K. Effect of tyrosine kinase inhibitor in patients with chronic myeloid leukemia (cytogenetic, molecular response) in Mosul. Ann. coll. Med. Mosul [Internet]. 2018 Dec. 1 [cited 2025 Sep. 9];40(2):1-8. Available from: https://ojs.uomosul.edu.iq/index.php/mmed/article/view/37208